Search results
Dr. Ferenc Darvas - Chairman of the Board. Dr. Ferenc Darvas is one of the true pioneers in the process intensification involved in modern chemistry. Dr. Darvas conceived the first industrialized solution-phase combinatorial synthesis technology (CMT). This was realized by ComGenex, the first European combinatorial chemistry corporation in 1992.
Darvas is a serial inventor and entrepreneur, founder, and president of Darholding, Inc., one of the largest upstream technology networks in the CEE region. The network members export to over 70 countries. The network has affiliates/firms/spinoffs in the USA, UK, IE, with a track record since 1983. Dr.
Ferenc Darvas's 117 research works with 2,386 citations and 18,381 reads, including: Chemistry‐Related Innovations in Space, Benefits of Flow Chemistry.
Dr. Darvas is a serial inventor and entrepreneur, founder, and president of Darholding, Inc. Darvas’s achievements include molecular modeling, process intensification, combinatorial chemistry, flow chemistry, nanotechnology, and space chemistry.
Feb 10, 2011 · Ferenc Darvas, Florida International University, Herbert Wertheim College of Medicine, Faculty Member. Studies Social Sciences, Sociology, and Management. M.S. in medicinal chemistry, M.S. in computer sciences, Ph.D. in exp. biology, innovator.
Aug 5, 2016 · Dr. Darvas is recognized as an efficient advocate of ACS in Europe and for Hungarian chemists overseas; he co-founded the Hungary ACS International Chemical Sciences Chapter in 2001, which he chaired for several years.
Ferenc Darvas is Chairman/President/Founder at Thalesnano. See Ferenc Darvas's compensation, career history, education, & memberships.
